Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zebrafish | 3 | 2018 | 3036 | 0.570 |
Why?
|
| Sexual Development | 1 | 2016 | 39 | 0.550 |
Why?
|
| Germ Cells | 2 | 2018 | 644 | 0.520 |
Why?
|
| Meiosis | 1 | 2018 | 326 | 0.520 |
Why?
|
| Zebrafish Proteins | 2 | 2018 | 1019 | 0.470 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2018 | 661 | 0.460 |
Why?
|
| Testis | 1 | 2016 | 783 | 0.430 |
Why?
|
| PTEN Phosphohydrolase | 8 | 2018 | 1120 | 0.350 |
Why?
|
| Transcription Factors | 4 | 2016 | 12165 | 0.220 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10470 | 0.220 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2018 | 25 | 0.150 |
Why?
|
| Oogenesis | 1 | 2018 | 125 | 0.140 |
Why?
|
| Spermatogenesis | 1 | 2018 | 260 | 0.140 |
Why?
|
| G1 Phase | 1 | 2018 | 403 | 0.140 |
Why?
|
| HMGB Proteins | 1 | 2016 | 45 | 0.140 |
Why?
|
| Sex Differentiation | 1 | 2016 | 73 | 0.140 |
Why?
|
| Sex Determination Processes | 1 | 2016 | 61 | 0.130 |
Why?
|
| Sex Chromosomes | 1 | 2016 | 101 | 0.130 |
Why?
|
| Lipogenesis | 1 | 2018 | 217 | 0.130 |
Why?
|
| Cyclins | 1 | 2018 | 605 | 0.130 |
Why?
|
| Elafin | 1 | 2014 | 30 | 0.120 |
Why?
|
| Repressor Proteins | 2 | 2016 | 2982 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2017 | 633 | 0.100 |
Why?
|
| SOX9 Transcription Factor | 1 | 2013 | 145 | 0.100 |
Why?
|
| Therapies, Investigational | 1 | 2013 | 110 | 0.100 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 428 | 0.100 |
Why?
|
| Gallbladder Neoplasms | 1 | 2014 | 190 | 0.100 |
Why?
|
| Extremities | 1 | 2017 | 870 | 0.100 |
Why?
|
| Body Patterning | 1 | 2016 | 634 | 0.100 |
Why?
|
| Prostatic Neoplasms | 4 | 2018 | 11101 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2013 | 1059 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2013 | 9614 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2016 | 3612 | 0.090 |
Why?
|
| PAX2 Transcription Factor | 1 | 2010 | 86 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2018 | 2846 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2018 | 8314 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1625 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 507 | 0.080 |
Why?
|
| Drosophila | 1 | 2016 | 1513 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2013 | 8637 | 0.080 |
Why?
|
| MicroRNAs | 3 | 2013 | 3804 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2017 | 2881 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2015 | 809 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 756 | 0.080 |
Why?
|
| Animals | 15 | 2018 | 169222 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2016 | 2428 | 0.070 |
Why?
|
| Drosophila Proteins | 1 | 2016 | 1712 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 4904 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2015 | 4146 | 0.060 |
Why?
|
| Androgens | 1 | 2013 | 1281 | 0.060 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 1888 | 0.060 |
Why?
|
| Chromatin | 1 | 2017 | 2981 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 1351 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2800 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 2884 | 0.060 |
Why?
|
| Androgen Antagonists | 1 | 2013 | 1412 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 4525 | 0.060 |
Why?
|
| Mice, Transgenic | 5 | 2014 | 9556 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 2953 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2010 | 984 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2015 | 12797 | 0.050 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2013 | 1399 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2429 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2011 | 2058 | 0.050 |
Why?
|
| Hematologic Neoplasms | 1 | 2013 | 1907 | 0.050 |
Why?
|
| Mice | 11 | 2018 | 82024 | 0.050 |
Why?
|
| Endometrial Neoplasms | 1 | 2010 | 1382 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 3409 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 5799 | 0.040 |
Why?
|
| Stem Cells | 1 | 2012 | 3537 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 5 | 2018 | 22381 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2014 | 23642 | 0.040 |
Why?
|
| Cell Line, Tumor | 4 | 2018 | 17128 | 0.040 |
Why?
|
| Ambystoma mexicanum | 1 | 2017 | 51 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 2014 | 1676 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 14163 | 0.030 |
Why?
|
| Male | 9 | 2018 | 364641 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 2456 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2013 | 5024 | 0.030 |
Why?
|
| Female | 7 | 2018 | 397113 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 381 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 800 | 0.030 |
Why?
|
| Melanoma | 1 | 2011 | 5706 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2013 | 147 | 0.030 |
Why?
|
| Obesity | 1 | 2015 | 13091 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2017 | 724 | 0.030 |
Why?
|
| Cytosine | 1 | 2013 | 213 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2013 | 5902 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2014 | 663 | 0.020 |
Why?
|
| Luciferases | 1 | 2013 | 714 | 0.020 |
Why?
|
| Phenylthiohydantoin | 1 | 2013 | 207 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2013 | 466 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2013 | 353 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1698 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 2014 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 515 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2017 | 19017 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2014 | 965 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2473 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2011 | 661 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 1335 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2017 | 11665 | 0.020 |
Why?
|
| Nitriles | 1 | 2013 | 980 | 0.020 |
Why?
|
| Benzamides | 1 | 2013 | 1377 | 0.020 |
Why?
|
| Models, Biological | 2 | 2013 | 9493 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 2660 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4576 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2906 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 2936 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 21206 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 2392 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3618 | 0.010 |
Why?
|
| RNA Interference | 1 | 2013 | 2830 | 0.010 |
Why?
|
| Humans | 11 | 2018 | 767991 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2824 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2018 | 14486 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2012 | 4176 | 0.010 |
Why?
|
| Liver | 1 | 2015 | 7574 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12828 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9521 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11068 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18344 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13658 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 30211 | 0.010 |
Why?
|
| Adult | 2 | 2015 | 223583 | 0.000 |
Why?
|
| Neoplasms | 1 | 2016 | 22365 | 0.000 |
Why?
|
| Middle Aged | 1 | 2010 | 223422 | 0.000 |
Why?
|
Concepts
(127)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_